Vutrisiran
Vutrisiran (ALN-TTRsc02) is a liver-directed, investigational, small interfering ribonucleic acid (siRNA) agent. Vutrisiran can be used for transthyretin (TTR) -mediated amyloidosis research[1].
Product Specifications
CAS Number
1867157-35-4
Product Name Alternative
ALN-TTRsc02
UNSPSC
12352208
Target
Small Interfering RNA (siRNA) ; Transthyretin (TTR)
Type
Oligonucleotides
Related Pathways
Epigenetics; Neuronal Signaling
Applications
Neuroscience-Neuromodulation
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/vutrisiran.html
Purity
97.37
Solubility
H2O : ≥ 20 mg/mL
Smiles
[Vutrisiran]
Molecular Formula
C530H715F9N171O323P43S6
Molecular Weight
16345.00
References & Citations
[1]Bahru A Habtemariam, et al. Single-Dose Pharmacokinetics and Pharmacodynamics of Transthyretin Targeting N-acetylgalactosamine-Small Interfering Ribonucleic Acid Conjugate, Vutrisiran, in Healthy Subjects. Clin Pharmacol Ther. 2021 Feb;109 (2) :372-382.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, sealed storage, away from moisture)
Scientific Category
Oligonucleotides
Clinical Information
Phase 3
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
VAng-Lsx03989-50gEcoli 50 µg (E. coli)
Recombinant Legionella Pneumophila aroB Protein (aa 1-369) (strain Corby)
Sign In for Pricing
View Details ![2-Amino-3-methyl-3H-imidazo[4,5-F]isoquinoline Hydrobromide](https://cdn.genprice.uk/genprice/uk/genprice3.webp)
002359 50 mg
2-Amino-3-methyl-3H-imidazo[4,5-F]isoquinoline Hydrobromide
Sign In for Pricing
View Details OG-3-5MG 5 mL
3nm Dodecanethiol Stabilized Gold Nanoparticles (dried)
Sign In for Pricing
View Details